Oxford Nanopore share price: set for boom or bust?

The Oxford Nanopore (LON: ONT) share price got off to a great start after its IPO. But where will this growth stock go next?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

To see a successful IPO, look no further than Oxford Nanopore (LSE: ONT). The shares opened above their offer price of 425p on 30 September. And the Oxford Nanopore share price reached as high as 645p the day after, though it has dropped back to 550p since.

Biotechnology stocks have attracted a lot of attention during the pandemic. And with a view to adding a growth stock to my income-dominated portfolio, I’m wondering whether Oxford Nanopore is the one for me to buy.

I try to invest in things I understand. But technology advances make the understanding harder and harder. Even with a background in biological sciences, some of the latest developments leave my head spinning.

The company specialises in DNA and RNA sequencing. And that’s come to the fore since Covid-19 arrived. It provides a means to identify different strains of the virus, for example. For it to be any use, though, scientists need to be able to identify a DNA sequence faster than a virus can evolve. If a new strain showed up every month, but it took three months of tedious lab work to sequence it… well, that’s the value of a technology like this. A value for the Oxford Nanopore share price, mind, is harder to pin down.

Genome sequencing

Genome sequencing is not new, and there are many companies out there that do various forms of it. Even nanopore sequencing has been about 25 years in the making. It does seem impressive, though, with nanopore devices able to be used pretty much anywhere without needing access to big labs. But who holds what patents, how exclusive are they, and what do they specifically protect? I have no idea, and that’s one problem I face when I think of investing.

If I don’t understand enough about a technology, or about a specific company’s version of it, at least I understand how a company works. You know, revenue, profit, margins, cash flow, debt… all that stuff. On that front, there’s not much to go on just yet. The firm offered its first products in 2014. By 2020, revenue had grown to a still modest £113.9m. And Nanopore recorded a net loss of £61.2m.

Still, that revenue had doubled from 2019. And for the first six months of the current year, sales are up 22%. Estimates suggest there’s a lot more to come. A report by Grand View Research suggests revenue in the sector could be set to exceed £10bn by 2027. If the company can grab a sizeable share of that, the Oxford Nanopore share price might soar.

Oxford Nanopore share price valuation

But back to valuation. My Motley Fool colleague Zaven Boyrazian has worked out that the stock is on a price-to-sales ratio (P/S) of around 40. I’m generally more comfortable with companies on a P/S of, maybe, two or less.

So I’m seeing an advanced technology stock with exciting market potential, but with the shares on a very high valuation. Stocks like that can easily go either way. Right now, sticking closely to the buy-what-you-know theme, I just don’t understand enough to buy. But I will do more research into Oxford Nanopore.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

After the FTSE 100 broke 9,000 points, does the UK market look overvalued?

The FTSE 100 went past 9,000 points this week but Mark Hartley says there are still bargains out there and…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Nvidia stock hit an all-time high this week. But could it be a bargain, even now?

After the Nvidia stock hit an all-time high this week, might it still be an attractive opportunity for our writer's…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the FTSE 100 hits an all-time high, I’m following Warren Buffett’s advice!

Billionaire investor Warren Buffett is a font of stock market wisdom. Our writer reflects on his approach, as the FTSE…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

The FTSE 100 reached an all-time high this week. Is it too late to invest?

The FTSE 100 hit a new all-time high level over the past few days. Our writer explains why he thinks…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

Here’s how £9,000 in savings could be used to target £343 a month of passive income

Christopher Ruane sets out a passive income plan that he reckons could help someone make sizeable sums over time without…

Read more »

ISA Individual Savings Account
Investing Articles

How to build a Stocks and Shares ISA with a 6% dividend yield

It’s easy to build an investment portfolio with a high dividend yield today. But investors need to manage risk carefully,…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

How risky is switching from cash savings to a Stocks and Shares ISA?

The UK government is making moves to encourage cash savers to consider investing via Stocks and Shares ISAs. But what…

Read more »

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

4,985 shares of this FTSE dividend star pay an income equal to the State Pension!

Zaven Boyrazian calculates how many shares investors would have to buy to generate enough income to match the UK State…

Read more »